Aditi Kulkarni

Aditi Kulkarni

Auto-generated profile, based on publicly available information

Aditi Kulkarni

University of North Carolina at Chapel Hill 14 Chapel Hill, NC

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2026 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
HGHuaibin Ge
Huaibin Ge
HLHousaiyin Li
Housaiyin Li
AKAditi Kulkarni
Aditi Kulkarni
ZCZhangguo Chen
Zhangguo Chen
PUPragati Upadhyay
Pragati Upadhyay
Jing WangJing Wang
Jing Wang
Purpose: Immune checkpoint inhibitors (ICI) elicit variable responses in head and neck squamous cell carcinoma (HNSCC), yet mechanisms driving major pathologic responses (MPR) remain poorly defined. We sought to evaluate longitudinal CD8 T-cell repertoire evolution to identify determinants of MPR. Patients and Methods: We analyzed high-resolution single-cell T-cell receptor (TCR) sequencing data from paired pretreatment and posttreatment CD8 tumor-infiltrating lymphocytes obtained from patients with HNSCC treated with neoadjuvant anti–PD-1 combined with either anti–CTLA-4 or anti–LAG3. Results: Contrary to the clonal replacement hypothesis, posttreatment CD8 T-cell pools were dominated by preexisting TCR clones regardless of clinical outcome. MPR was uniquely characterized by higher abundance and greater expansion magnitude of super-expanded clones. We developed the TCR adaptivity index (TAI) to quantify coordinate flux (expansion and contraction) of all TCR clones detected across pretreatment and posttreatment time points; this index emerged as the most significant parameter associated with MPR. Importantly, clonal expansion in non-MPR was uncoupled from the productive, therapy-induced transcriptional reprogramming—characterized by markers of effector vigor and cellular fitness—that was observed in MPR. Furthermore, expansion dynamics positively correlated with predicted tumor reactivity as calculated by the tumor-reactive signature (TRS) score. Finally, a TRS-integrated TAI remained significantly correlated with MPR. Conclusions: Dual-ICI drives MPR predominantly through the adaptivity and functional reprogramming of preexisting immunity. Successful therapy relies on a coordinate repertoire response that promotes transition of putative tumor-reactive super-expanders into productive functional states. TRS-integrated TAI provides a high-throughput framework incorporating clonal dynamics and functional reprogramming to predict therapeutic efficacy.

5 October 2026
Verified
Other
Open access
PDF file
HBHridesh Banerjee
Hridesh Banerjee
OOOnyedikachi V. Onyekachi
Onyedikachi V. Onyekachi
HNHector Nieves-Rosado
Hector Nieves-Rosado
BMBenjamin M. Murter
Benjamin M. Murter
AKAditi Kulkarni
Aditi Kulkarni
LKLawrence P. Kane
Lawrence P. Kane
Individual correlation histograms for FOXO1 and nuclear stain DRAQ5, obtained from WT and Tim-3Treg KO mice.

5 October 2026
Verified
Other
Open access
PDF file
HBHridesh Banerjee
Hridesh Banerjee
OOOnyedikachi V. Onyekachi
Onyedikachi V. Onyekachi
HNHector Nieves-Rosado
Hector Nieves-Rosado
BMBenjamin M. Murter
Benjamin M. Murter
AKAditi Kulkarni
Aditi Kulkarni
LKLawrence P. Kane
Lawrence P. Kane
Quantitation of T cell populations recovered from MC38 TIL of WT and Tim-3Treg KO mice, with or without Treg-specific co-expression of Bcl-2.

5 October 2026
Verified
Other
Open access
HBHridesh Banerjee
Hridesh Banerjee
OOOnyedikachi V. Onyekachi
Onyedikachi V. Onyekachi
HNHector Nieves-Rosado
Hector Nieves-Rosado
BMBenjamin M. Murter
Benjamin M. Murter
AKAditi Kulkarni
Aditi Kulkarni
LKLawrence P. Kane
Lawrence P. Kane
Differentially expressed genes between Tim-3 KO and WT TIL Treg

5 October 2026
Verified
Other
Open access
PDF file
HBHridesh Banerjee
Hridesh Banerjee
OOOnyedikachi V. Onyekachi
Onyedikachi V. Onyekachi
HNHector Nieves-Rosado
Hector Nieves-Rosado
BMBenjamin M. Murter
Benjamin M. Murter
AKAditi Kulkarni
Aditi Kulkarni
LKLawrence P. Kane
Lawrence P. Kane
Differential gene expression in WT and Tim-3 KO tumor Treg.

14 August 2026
Verified
Other
Open access
HGHuaibin Ge
Huaibin Ge
HLHousaiyin Li
Housaiyin Li
AKAditi Kulkarni
Aditi Kulkarni
ZCZhangguo Chen
Zhangguo Chen
PUPragati Upadhyay
Pragati Upadhyay
Jing WangJing Wang
Jing Wang
Supplemental Table 10-pre_super_clones_NR_post_vs_baseline_DEG_sig